Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 15;29:42. doi: 10.1186/s12929-022-00824-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

PMC Copyright notice

Fig. 4 — KRT17 regulates CD44 and EGFR expression via activations of integrin/Src/β-catenin signaling cascade. A CD44 protein expression in C9IV3 and HSC3 cells transfected with siCon or siKRT17 was determined by western blotting (left panel), and EGFR expression was assessed by qPCR and western blotting (middle and right panels). B Left, Western blotting was used to assess the efficacy of three siRNAs (siβ-catenin-1, -2, -3) designed to specifically silence β-catenin in C9IV3 and HSC3 cells (left panel). Siβ-catenin-2 (siβ-catenin) that caused most effective β-catenin suppression was utilized to examine mRNA and protein expression of CD44 and EGFR in C9IV3 and HSC3 cells (middle and right). C The canonical Wnt/β-catenin inhibitor, adavivint (1 μM), was used to treat C9IV3 and HSC3 cells for 48 h before analyzing expressions of CD44 and EGFR at both mRNA and protein levels. D Expression efficiency of the β-catenin cDNA plasmid (O-β-catenin) was determined at protein level (left panel) prior to combinatorial treatment with either siKRT17 (middle panel) or dasatinib (right panel) for assessing their impacts on CD44 and EGFR expression in C9IV3 and HSC3 cells. Cells were transfected with the indicated siRNA or plasmids for 24 h, and then treated with 1 μM dasatinib for 48 h. E Correlation between the gene expression levels of KRT17 and ITGB4, CD44 or EGFR in clinical HNSCC specimens using TCGA database (n = 566)